United States Biotechnology & Medical Research

Kiniksa Pharmaceuticals Ltd (KNSA)

Track

Over the past 90 days, Kiniksa Pharmaceuticals Ltd insiders have executed 12 transactions, all of which were sales totaling approximately $53.75 million. These planned and proposed sales involved key executives, including the CEO and Chief Medical Officer, occurring amidst a 50.6% stock price increase and following the company's most recent earnings report.
Ticker: KNSA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kiniksa Pharmaceuticals Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Paolini John F.
CHIEF MEDICAL OFFICER
3 sales — total 6,275,533 USD
Planned sale 1 May 2026
Value US$2,518,866.30 | Price 376.11 | Shares 31,732
Planned sale 1 May 2026
Value US$887,430.41 | Price 107.91 | Shares 24,352
Proposed sale 1 May 2026
Value US$3,137,710.00 | Price 53.71 | Shares 58,424
Planned sale 1 May 2026
Value US$528,010.90 | Price 329.04 | Shares 2,804
Planned sale 30 Apr 2026
Value US$115,635.41 | Price 54.01 | Shares 2,141
Planned sale 29 Apr 2026
Value US$1,217,601.44 | Price 54.01 | Shares 22,544
Planned sale 28 Apr 2026
Value US$2,795,535.00 | Price 54.02 | Shares 51,750
Planned sale 28 Apr 2026
Value US$12,671,863.92 | Price 52.02 | Shares 243,596
Planned sale 28 Apr 2026
Value US$5,850,749.31 | Price 51.47 | Shares 113,673
Planned sale 28 Apr 2026
Value US$3,763,843.05 | Price 50.43 | Shares 74,635
Proposed sale 28 Apr 2026
Value US$17,780,309.00 | Price 51.60 | Shares 344,591
Planned sale 28 Apr 2026
Value US$656,259.90 | Price 50.10 | Shares 13,099
Planned sale 9 Apr 2026
Value US$309,321.25 | Price 46.69 | Shares 6,625
Proposed sale 9 Apr 2026
Value US$309,321.00 | Price 46.69 | Shares 6,625
Planned sale 9 Apr 2026
Value US$79,513.07 | Price 46.69 | Shares 1,703
Proposed sale 9 Apr 2026
Value US$79,513.00 | Price 46.69 | Shares 1,703
Planned sale 6 Apr 2026
Value US$363,972.78 | Price 50.01 | Shares 7,278
Proposed sale 6 Apr 2026
Value US$10,979,550.00 | Price 50.00 | Shares 219,591
Planned sale 6 Apr 2026
Value US$114,988.86 | Price 48.58 | Shares 2,367
Proposed sale 6 Apr 2026
Value US$114,989.00 | Price 48.58 | Shares 2,367
Planned sale 6 Apr 2026
Value US$345,050.00 | Price 50.00 | Shares 6,901
Proposed sale 6 Apr 2026
Value US$1,000,000.00 | Price 50.00 | Shares 20,000
Planned sale 9 Mar 2026
Value US$866,583.84 | Price 46.24 | Shares 18,741
Planned sale 9 Mar 2026
Value US$819,573.98 | Price 45.58 | Shares 17,981
Proposed sale 9 Mar 2026
Value US$1,686,179.00 | Price 45.92 | Shares 36,722
Planned sale 2 Mar 2026
Value US$262,386.88 | Price 45.92 | Shares 5,714
Planned sale 2 Mar 2026
Value US$997,368.24 | Price 44.88 | Shares 22,223
Planned sale 2 Mar 2026
Value US$533,184.60 | Price 44.20 | Shares 12,063
Proposed sale 2 Mar 2026
Value US$1,792,970.00 | Price 44.82 | Shares 40,000
Planned sale 12 Feb 2026
Value US$121,050.00 | Price 45.00 | Shares 2,690
Planned sale 10 Feb 2026
Value US$4,950.00 | Price 45.00 | Shares 110
Planned sale 9 Feb 2026
Value US$381,719.32 | Price 43.72 | Shares 8,731
Planned sale 9 Feb 2026
Value US$390,534.90 | Price 42.85 | Shares 9,114
Planned sale 4 Feb 2026
Value US$117,142.04 | Price 45.02 | Shares 2,602
Planned sale 4 Feb 2026
Value US$117,142.04 | Price 45.02 | Shares 2,602
Planned sale 3 Feb 2026
Value US$567,142.56 | Price 45.27 | Shares 12,528
Planned sale 3 Feb 2026
Value US$567,142.56 | Price 45.27 | Shares 12,528
Planned sale 2 Feb 2026
Value US$37,350.00 | Price 45.00 | Shares 830
Planned sale 2 Feb 2026
Value US$37,350.00 | Price 45.00 | Shares 830
Planned sale 8 Jan 2026
Value US$502,680.00 | Price 41.89 | Shares 12,000
Planned sale 15 Dec 2025
Value US$500,714.88 | Price 41.56 | Shares 12,048
Planned sale 15 Dec 2025
Value US$835,554.79 | Price 41.51 | Shares 20,129
Proposed sale 15 Dec 2025
Value US$2,444,530.00 | Price 41.51 | Shares 58,889
Planned sale 8 Dec 2025
Value US$1,777,473.09 | Price 41.49 | Shares 42,841
Proposed sale 8 Dec 2025
Value US$3,015,917.00 | Price 41.49 | Shares 72,686
Planned sale 26 Nov 2025
Value US$8,578.00 | Price 42.89 | Shares 200
Proposed sale 26 Nov 2025
Value US$2,075,190.00 | Price 42.89 | Shares 48,384
Planned sale 17 Nov 2025
Value US$488,372.50 | Price 41.30 | Shares 11,825
Planned sale 17 Nov 2025
Value US$25,851.60 | Price 40.08 | Shares 645
Proposed sale 17 Nov 2025
Value US$514,225.00 | Price 41.24 | Shares 12,470
Planned sale 12 Nov 2025
Value US$814,706.00 | Price 40.94 | Shares 19,900
Planned sale 31 Oct 2025
Value US$3,065,609.88 | Price 37.14 | Shares 82,542
Proposed sale 31 Oct 2025
Value US$3,065,800.00 | Price 37.14 | Shares 82,542
Planned sale 28 Oct 2025
Value US$4,100.00 | Price 41.00 | Shares 100
Proposed sale 28 Oct 2025
Value US$820,000.00 | Price 41.00 | Shares 20,000
Proposed sale 28 Oct 2025
Value US$820,000.00 | Price 41.00 | Shares 20,000
Planned sale 22 Oct 2025
Value US$3,781,653.70 | Price 38.83 | Shares 97,390
Planned sale 21 Oct 2025
Value US$1,524,862.87 | Price 38.77 | Shares 39,331
Planned sale 20 Oct 2025
Value US$877,386.48 | Price 39.32 | Shares 22,314
Planned sale 20 Oct 2025
Value US$3,839,628.54 | Price 38.81 | Shares 98,934
Proposed sale 20 Oct 2025
Value US$10,035,561.00 | Price 38.90 | Shares 257,969
Planned sale 20 Oct 2025
Value US$520,267.85 | Price 39.31 | Shares 13,235
Planned sale 20 Oct 2025
Value US$1,442,513.60 | Price 38.72 | Shares 37,255
Proposed sale 20 Oct 2025
Value US$1,962,914.00 | Price 38.88 | Shares 50,490
Planned sale 14 Oct 2025
Value US$21,008.47 | Price 37.99 | Shares 553
Planned sale 14 Oct 2025
Value US$444,834.75 | Price 37.65 | Shares 11,815
Proposed sale 14 Oct 2025
Value US$465,786.00 | Price 37.66 | Shares 12,368
Planned sale 29 Sep 2025
Value US$1,609,860.00 | Price 38.33 | Shares 42,000
Proposed sale 29 Sep 2025
Value US$1,609,716.00 | Price 38.33 | Shares 42,000
Planned sale 15 Sep 2025
Value US$13,172.00 | Price 37.00 | Shares 356
Planned sale 15 Sep 2025
Value US$584,803.80 | Price 36.45 | Shares 16,044
Proposed sale 15 Sep 2025
Value US$598,016.00 | Price 36.46 | Shares 16,400
Planned sale 5 Sep 2025
Value US$477,451.74 | Price 35.66 | Shares 13,389
Proposed sale 5 Sep 2025
Value US$477,497.00 | Price 35.66 | Shares 13,389
Planned sale 4 Sep 2025
Value US$3,028,825.92 | Price 35.52 | Shares 85,271
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-05 2026-05-01 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
31,732 +3.1%
376.11
US$2,518,866 		31,732 +3.1% 376.11 US$2,518,866
2026-05-05 2026-05-01 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
24,352 -5.8%
107.91
US$887,430 		24,352 -5.8% 107.91 US$887,430
2026-05-01 2026-05-01 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
2,804 +20.2%
329.04
US$528,011 		2,804 +20.2% 329.04 US$528,011
2026-05-01 2026-05-01 PrS Proposed sale
Paolini John F.

Officer

Officer
58,424
53.71
US$3,137,710 		58,424 53.71 US$3,137,710
2026-04-30 2026-04-30 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
2,141 -100.0%
54.01
US$115,635 		2,141 -100.0% 54.01 US$115,635
2026-04-30 2026-04-29 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
22,544 -100.0%
54.01
US$1,217,601 		22,544 -100.0% 54.01 US$1,217,601
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
51,750 -100.0%
54.02
US$2,795,535 		51,750 -100.0% 54.02 US$2,795,535
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
243,596 -82.5%
52.02
US$12,671,864 		243,596 -82.5% 52.02 US$12,671,864
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
113,673 -27.8%
51.47
US$5,850,749 		113,673 -27.8% 51.47 US$5,850,749
2026-04-30 2026-04-28 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
74,635 -15.4%
50.43
US$3,763,843 		74,635 -15.4% 50.43 US$3,763,843
2026-04-29 2026-04-28 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
13,099 -51.1%
50.10
US$656,260 		13,099 -51.1% 50.10 US$656,260
2026-04-28 2026-04-28 PrS Proposed sale
Patel Sanj K

Officer; Director

Executive Director
344,591
51.60
US$17,780,309 		344,591 51.60 US$17,780,309
2026-04-13 2026-04-09 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
6,625 -19.5%
46.69
US$309,321 		6,625 -19.5% 46.69 US$309,321
2026-04-13 2026-04-09 PlS Planned sale
Moat Ross

CHIEF OPERATING OFFICER

Officer
1,703 -12.4%
46.69
US$79,513 		1,703 -12.4% 46.69 US$79,513
2026-04-09 2026-04-09 PrS Proposed sale
Moat Ross

Officer

Officer
1,703
46.69
US$79,513 		1,703 46.69 US$79,513
2026-04-09 2026-04-09 PrS Proposed sale
2.2
Megna Michael R

Officer

Officer
6,625
46.69
US$309,321 		6,625 46.69 US$309,321
2026-04-08 2026-04-06 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
7,278 -100.0%
50.01
US$363,973 		7,278 -100.0% 50.01 US$363,973
2026-04-08 2026-04-06 PlS Planned sale
Moat Ross

CHIEF OPERATING OFFICER

Officer
2,367 -16.4%
48.58
US$114,989 		2,367 -16.4% 48.58 US$114,989
2026-04-08 2026-04-06 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
6,901 -35.5%
50.00
US$345,050 		6,901 -35.5% 50.00 US$345,050
2026-04-06 2026-04-06 PrS Proposed sale
2.5
Quart Barry D

Director

Non-Executive Director
20,000
50.00
US$1,000,000 		20,000 50.00 US$1,000,000
2026-04-06 2026-04-06 PrS Proposed sale
Patel Sanj K

Officer; Director

Executive Director
219,591
50.00
US$10,979,550 		219,591 50.00 US$10,979,550
2026-04-06 2026-04-06 PrS Proposed sale
Moat Ross

Officer

Officer
2,367
48.58
US$114,989 		2,367 48.58 US$114,989
2026-03-11 2026-03-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
18,741 -60.8%
46.24
US$866,584 		18,741 -60.8% 46.24 US$866,584
2026-03-11 2026-03-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
17,981 -36.8%
45.58
US$819,574 		17,981 -36.8% 45.58 US$819,574
2026-03-09 2026-03-09 PrS Proposed sale
Ragosa Mark

Officer

Officer
36,722
45.92
US$1,686,179 		36,722 45.92 US$1,686,179
2026-03-04 2026-03-02 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
5,714 -8.5%
45.92
US$262,387 		5,714 -8.5% 45.92 US$262,387
2026-03-04 2026-03-02 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
22,223 -24.9%
44.88
US$997,368 		22,223 -24.9% 44.88 US$997,368
2026-03-04 2026-03-02 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
12,063 -11.9%
44.20
US$533,185 		12,063 -11.9% 44.20 US$533,185
2026-03-02 2026-03-02 PrS Proposed sale
Paolini John F.

Officer

Officer
40,000
44.82
US$1,792,970 		40,000 44.82 US$1,792,970
2026-02-12 2026-02-12 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
2,690 -17.7%
45.00
US$121,050 		2,690 -17.7% 45.00 US$121,050
2026-02-12 2026-02-10 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
110 -0.9%
45.00
US$4,950 		110 -0.9% 45.00 US$4,950
2026-02-11 2026-02-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
8,731 -41.9%
43.72
US$381,719 		8,731 -41.9% 43.72 US$381,719
2026-02-11 2026-02-09 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
9,114 -30.5%
42.85
US$390,535 		9,114 -30.5% 42.85 US$390,535
2026-02-04 2026-02-04 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
2,602 -17.2%
45.02
US$117,142 		2,602 -17.2% 45.02 US$117,142
2026-02-04 2026-02-04 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
2,602 -17.2%
45.02
US$117,142 		2,602 -17.2% 45.02 US$117,142
2026-02-04 2026-02-03 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
12,528 -50.0%
45.27
US$567,143 		12,528 -50.0% 45.27 US$567,143
2026-02-04 2026-02-03 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
12,528 -50.0%
45.27
US$567,143 		12,528 -50.0% 45.27 US$567,143
2026-02-04 2026-02-02 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
830 -6.2%
45.00
US$37,350 		830 -6.2% 45.00 US$37,350
2026-02-04 2026-02-02 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
830 -6.2%
45.00
US$37,350 		830 -6.2% 45.00 US$37,350
2026-01-09 2026-01-08 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
12,000 -38.6%
41.89
US$502,680 		12,000 -38.6% 41.89 US$502,680
2025-12-17 2025-12-15 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
12,048 -42.0%
41.56
US$500,715 		12,048 -42.0% 41.56 US$500,715
2025-12-17 2025-12-15 PlS Planned sale
2.5
Quart Barry D
Non-Executive Director
20,129 -61.6%
41.51
US$835,555 		20,129 -61.6% 41.51 US$835,555
2025-12-15 2025-12-15 PrS Proposed sale
2.5
Quart Barry D

Director

Non-Executive Director
58,889
41.51
US$2,444,530 		58,889 41.51 US$2,444,530
2025-12-10 2025-12-08 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
42,841 -58.0%
41.49
US$1,777,473 		42,841 -58.0% 41.49 US$1,777,473
2025-12-08 2025-12-08 PrS Proposed sale
Ragosa Mark

Officer

Officer
72,686
41.49
US$3,015,917 		72,686 41.49 US$3,015,917
2025-12-01 2025-11-26 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
200 -0.9%
42.89
US$8,578 		200 -0.9% 42.89 US$8,578
2025-11-26 2025-11-26 PrS Proposed sale
Tessari Eben

Officer

Officer
48,384
42.89
US$2,075,190 		48,384 42.89 US$2,075,190
2025-11-19 2025-11-17 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
11,825 -34.2%
41.30
US$488,372 		11,825 -34.2% 41.30 US$488,372
2025-11-19 2025-11-17 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
645 -1.8%
40.08
US$25,852 		645 -1.8% 40.08 US$25,852
2025-11-17 2025-11-17 PrS Proposed sale
Tessari Eben

Officer

Officer
12,470
41.24
US$514,225 		12,470 41.24 US$514,225
2025-11-14 2025-11-12 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
19,900 -39.0%
40.94
US$814,706 		19,900 -39.0% 40.94 US$814,706
2025-11-04 2025-10-31 PlS Planned sale
Paolini John F.

CHIEF MEDICAL OFFICER

Officer
82,542 -57.4%
37.14
US$3,065,610 		82,542 -57.4% 37.14 US$3,065,610
2025-10-31 2025-10-31 PrS Proposed sale
Paolini John F.

Officer

Officer
82,542
37.14
US$3,065,800 		82,542 37.14 US$3,065,800
2025-10-30 2025-10-28 PlS Planned sale
Ragosa Mark

CHIEF FINANCIAL OFFICER

Officer
100 -0.3%
41.00
US$4,100 		100 -0.3% 41.00 US$4,100
2025-10-28 2025-10-28 PrS Proposed sale
Ragosa Mark

Officer

Officer
20,000
41.00
US$820,000 		20,000 41.00 US$820,000
2025-10-28 2025-10-28 PrS Proposed sale
Ragosa Mark

Officer

Officer
20,000
41.00
US$820,000 		20,000 41.00 US$820,000
2025-10-22 2025-10-22 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
97,390 -46.6%
38.83
US$3,781,654 		97,390 -46.6% 38.83 US$3,781,654
2025-10-22 2025-10-21 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
39,331 -26.0%
38.77
US$1,524,863 		39,331 -26.0% 38.77 US$1,524,863
2025-10-22 2025-10-20 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
22,314 -16.6%
39.32
US$877,386 		22,314 -16.6% 39.32 US$877,386
2025-10-22 2025-10-20 PlS Planned sale
Patel Sanj K

CHAIRMAN & CEO

Executive Director
98,934 -42.5%
38.81
US$3,839,629 		98,934 -42.5% 38.81 US$3,839,629
2025-10-22 2025-10-20 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
13,235 -32.9%
39.31
US$520,268 		13,235 -32.9% 39.31 US$520,268
2025-10-22 2025-10-20 PlS Planned sale
2.2
Megna Michael R

CHIEF ACCOUNTING OFFICER

Officer
37,255 -48.0%
38.72
US$1,442,514 		37,255 -48.0% 38.72 US$1,442,514
2025-10-20 2025-10-20 PrS Proposed sale
Patel Sanj K

Officer; Director

Executive Director
257,969
38.90
US$10,035,561 		257,969 38.90 US$10,035,561
2025-10-20 2025-10-20 PrS Proposed sale
2.2
Megna Michael R

Officer

Officer
50,490
38.88
US$1,962,914 		50,490 38.88 US$1,962,914
2025-10-16 2025-10-14 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
553 -1.9%
37.99
US$21,008 		553 -1.9% 37.99 US$21,008
2025-10-16 2025-10-14 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
11,815 -28.8%
37.65
US$444,835 		11,815 -28.8% 37.65 US$444,835
2025-10-14 2025-10-14 PrS Proposed sale
Tessari Eben

Officer

Officer
12,368
37.66
US$465,786 		12,368 37.66 US$465,786
2025-10-01 2025-09-29 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
42,000 -54.9%
38.33
US$1,609,860 		42,000 -54.9% 38.33 US$1,609,860
2025-09-29 2025-09-29 PrS Proposed sale
Tessari Eben

Officer

Officer
42,000
38.33
US$1,609,716 		42,000 38.33 US$1,609,716
2025-09-17 2025-09-15 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
356 -1.0%
37.00
US$13,172 		356 -1.0% 37.00 US$13,172
2025-09-17 2025-09-15 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
16,044 -31.5%
36.45
US$584,804 		16,044 -31.5% 36.45 US$584,804
2025-09-15 2025-09-15 PrS Proposed sale
Tessari Eben

Officer

Officer
16,400
36.46
US$598,016 		16,400 36.46 US$598,016
2025-09-08 2025-09-05 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
13,389 -23.1%
35.66
US$477,452 		13,389 -23.1% 35.66 US$477,452
2025-09-05 2025-09-05 PrS Proposed sale
Tessari Eben

Officer

Officer
13,389
35.66
US$477,497 		13,389 35.66 US$477,497
2025-09-08 2025-09-04 PlS Planned sale
Tessari Eben

CHIEF OPERATING OFFICER

Officer
85,271 -65.7%
35.52
US$3,028,826 		85,271 -65.7% 35.52 US$3,028,826
Explore more

More insider trading research around Kiniksa Pharmaceuticals Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America